ADVERTISEMENT

Psychedelics News

Mydecine Innovations Group

Press Releases

1 Mar 2021

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

DENVER, March 01, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category committed...

By Microdose

Press Releases

24 Feb 2021

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Partnership Supports Mydecine’s Drug Development & Clinical Trials Provides Update on Debt Settlement *NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DENVER, Feb....

By Microdose

Press Releases

17 Feb 2021

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

DENVER, Feb....

By Microdose

Press Releases

3 Feb 2021

Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

DENVER, Feb....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

28 Jan 2021

Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

DENVER, Jan....

By Microdose

ADVERTISEMENT

Follow us on social

Latest News

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads